By Chelsea Naso ( October 10, 2019, 10:22 AM EDT) -- Belgium's UCB, advised by Covington & Burling, unveiled plans Thursday to snap up Latham & Watkins-led clinical stage biotech company Ra Pharma in a $2.1 billion deal, as UCB looks to bolster its potential in the rare disease space....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.